Consensus review of the clinical utility of dna content cytometry in prostate cancer
โ Scribed by T. Vincent Shankey; Ollie-Pekka Kallioniemi; James M. Koslowski; Michael L. Lieber; Brian H. Mayall; Gary Miller; Gary J. Smith
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 485 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0196-4763
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Preoperative diagnosis of follicular carcinoma of the thyroid remains a clinical challenge. This study determined the DNA content parameters of ploidy and proliferative activity levels from cells of normal thyroid tissue, follicular adenomas, and follicular carcinomas to evaluate if the
The prognostic significance of ploidy level was studied in prostatic carcinoma and compared with the prognostic significance of morphologic grade and clinical stage. A nonselected group of 145 patients was studied in whom prostatic carcinoma was diagnosed by fine-needle aspiration biopsy at the Karo
## Abstract ## Purpose To retrospectively evaluate the relationship between apparent diffusion coefficient (ADC) values and Gleason score (GS) in prostate cancer. ## Methods A total of 60 patients who underwent radical prostatectomy for clinically localized prostate cancer were selected for this
BACKGROUND. Bicalutamide (Casodex) is a new nonsteroidal antiandrogen developed for use in patients with prostate cancer. The efficacy and tolerability of bicalutamide as monotherapy and as combination therapy for patients with advanced prostate cancer have been evaluated in randomized clinical tria